| PHIN2029-2 | | Regulation and the medical-social environment | | Holder |
 |
| |
- Aspects économiques du développement du médicament | | |
|
| |
- Legislation and procedures applied to pharmaceutical industry, part a : legislation | | |
|
| |
- Legislation and procedures applied to pharmaceutical industry, part b : patents and protection | | |
|
| |
- Environnment macro-économique et pharmaco-économie | | |
|
| |
- CTD File (Common Technical Document) | | |
|
| |
- Regulations of preclinical and clinical studies, part a : pharmaceutical toxicological files | | |
|
| |
- Regulations of preclinical and clinical studies, part b : clinical studies | | |
|
| |
- Regulations of preclinical and clinical studies, part c : pediatric studies | | |
|
| |
- Specific regulatory issues, part a : medicine and herbal dietary supplement | | |
|
| |
- Aspects réglementaires particuliers, partim b : Préformulation et documentation du développement galénique | | |
|
